NX-1607 is an oral, small molecule inhibitor of casitas B-lineage lymphoma proto-oncogene-b (Cbl-b) that has been shown to enhance antigen recall, reduce T cell exhaustion and increase cytokine production upon T cell receptor stimulation, overcoming suppressive signals from the tumor microenvironment (TME).
Molecular Weight:
537.62
Purity:
99.0%
CAS Number:
[2573775-59-2]
Formula:
C30H34F3N5O
Target:
E1/E2/E3 Enzyme
* VAT and and shipping costs not included. Errors and price changes excepted
